ARCHIVES

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Tests Early Phase Study To Hasten Drug Development

August 31, 2007

“NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s

September 20, 1991

Study Finds Green Tea No Help In Advanced Prostate Cancer

March 28, 2003

NCI RFA Available: Minority-Based CCOPS

August 15, 1997

ACS, NBCC Weigh Involvement In March, Ask What Happens Next

October 31, 1997

Drug Marketing; Zeneca sues Eli Lilly, Claiming Misleading Promotion of Evista

March 12, 1999